Anti-Snake Venom Production is now a main focus of BIRAC

  • News
  • December 26, 2017

According to the reports, India is estimated to have the highest snakebite mortality in the world and with this regard, BIRAC took an initiative to research for developing novel tools, technologies and processes related to snake bite problem and the final product will optimize up to the level to work as Anti-snake venom.

In rural areas of tropical developing countries, snake bite is very common and is responsible for tens of thousands of deaths and disabilities every year. So, pertaining to these cases, BIRAC called research proposals on the development of novel and alternate ways of anti-snake venom (ASV) production; development of new diagnostics kits for the identification of the snake biting species; and characterization, evaluation, and validation facility for ASV.

This new programme will start soon and will the focus on cost-effective, novel and innovative approaches. BIRAC also focus on generating ASV with better product profiles and greater cost-effectiveness than current products in the market.

This program would incorporate a portion of the demonstrative need territories for presenting the proposition, for example, better approaches for creating ASV like recombinant immune response based ASV generation advances; identification of herbal/peptide and little atoms for conceivable upgrade of accessible window for administration; plant-made recombinant snakebite immunizing agent venom counter acting agent mixed drink; and a container Asian antidote venom – with high power antibody venom intended for a few nations over the South Asian locale, delivered in huge volumes and administered in a solitary dosage.

  • Related Posts

    MedTech Zone AMTZ Puts Vizag on the Science Map of India

    Vizag Science &Technology Cluster rated as one of the India’s Strategic Innovation Hubs Visakhapatnam, June 28 – In a significant boost to Vizag’s growing scientific stature, the Andhra Pradesh MedTech…

    • News
    • May 27, 2025
    • 293 views
    Ramping Up Community for JeevanRaksha during Disasters

    CBDM India 2025 will Champion Health Resilience and Local Response Bengaluru: As India and its neighbours continue to confront the double threat of increasing natural disasters and unpredictable man-made crises—including…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Natco Pharma shares dip over 2% after Rs 2,000-crore stake buy in South Africa’s Adcock Ingram

    Natco Pharma shares dip over 2% after Rs 2,000-crore stake buy in South Africa’s Adcock Ingram

    10, 000 Km is just a Number for Intercontinental Tele Surgery by SSIMantra

    10, 000 Km is just a Number for Intercontinental Tele Surgery by SSIMantra

    DGFT Extends Deadline on Application for Export of Pharma Grade Sugar

    DGFT Extends Deadline on Application for Export of Pharma Grade Sugar

    Bihar Healthcare is poised to be embraced by Robotic Surgery Mantra

    Bihar Healthcare is poised to be embraced by Robotic Surgery Mantra